Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tsamalaidze L, Stauffer JA, Arasi LC, et al
Methods Fifty-six subjects, categorized into renal function groups [normal, mild, moderate, severe, and end-stage renal disease (ESRD)], received a single subcutaneous dose of semaglutide 0.5 mg
Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
Whether the deglutathionylation requires a release or reorientation of the GSSR intermediate should depend on whether the four sulfur atoms of the disulfide substrate, GSH, and the active-site cysteinyl residue can be arranged like beads on string
US$ 29.94
US$ 28.65
US$ 21.14
